ReviewFrontiers in oncology2025

Metabolic reprogramming and therapeutic targeting in non-small cell lung cancer: emerging insights beyond the Warburg effect.

Hong Cai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.